The prestigious two-star safety rating for the PCI procedure, also known as angioplasty, was awarded to, from left, George Dangas, MD, PhD;
Annapoorna S. Kini, MD; and Samin K. Sharma, MD.
The Mount Sinai Hospital’s Cardiac Catheterization Laboratory has become the first to have three interventional cardiologists receive the highest two-star safety rating from the New York State Department of Health for percutaneous coronary interventions (PCI), also known as angioplasty. PCI—one of the most common procedures for patients with coronary artery disease—opens blocked arteries and restores normal blood flow to the heart.
The physicians recognized were Samin K. Sharma, MD, Director of Clinical and Interventional Cardiology at The Mount Sinai Hospital; Annapoorna S. Kini, MD, Zena and Michael A. Wiener Professor of Medicine at the Icahn School of Medicine at Mount Sinai; and George Dangas, MD, PhD, Professor of Medicine (Cardiology). They were awarded the two-star safety rating while performing a total of 7,247 PCI cases from 2011 to 2013. Dr. Sharma was one of only two interventional cardiologists in New York State to receive the two-star safety rating in two categories: non-emergency and emergency cases.
“I am very proud of Dr. Sharma, Dr. Kini, and Dr. Dangas, and our Cardiac Catheterization Laboratory team. They are true leaders in the field of interventional cardiology,” says Valentin Fuster, MD, PhD, Physician-in-Chief of The Mount Sinai Hospital, and Director of the Zena and Michael A. Wiener Cardiovascular Institute, and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health.
This marks the 18th consecutive year the Mount Sinai Catheterization Laboratory or its physicians have been awarded a two-star designation for safety rates significantly exceeding the statewide average. “At Mount Sinai Heart’s Cardiac Catheterization Laboratory, our patients’ safety is our No. 1 concern,” says Dr. Sharma, Anandi Lal Sharma Professor of Medicine in Cardiology at the Icahn School of Medicine at Mount Sinai.
The new data released by the Department of Health reports on the outcomes for patients at all 61 statewide cardiac catheterization labs. The report, “Percutaneous Coronary Interventions (PCI) in New York State 2011-2013,” tracked PCI data in overall, non-emergency, and emergency cases. During the three-year period, Mount Sinai’s Cardiac Catheterization Laboratory achieved a significantly higher safety level than the statewide average while performing 13,906 PCI cases, the largest number in New York. Mount Sinai’s risk-adjusted mortality rate (RAMR) for all cases was 0.75 percent, significantly lower than the statewide average, 1.04 percent. Also, Mount Sinai’s mortality rate for non-emergency cases, 0.49 percent, was significantly lower than the statewide average, 0.68 percent. The Mount Sinai Hospital’s readmission rate was also significantly lower than the statewide average.
“The achievement of such great results is quite remarkable given the high complexity of cases referred and likely due to the individualized, interdisciplinary patient care at Mount Sinai,” says Dr. Dangas, Director of Cardiovascular Innovation.
Dr. Kini, Director of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital, says, “This report measures the high-quality patient care and successful results our team of skilled interventional cardiologists and staff have been able to offer our patients each and every day.”